Dusanka Savic-Pavicevic

Prof. Dr. Dusanka Savic-Pavicevic

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2012 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MZMagdalena Zimoń
Magdalena Zimoń
JBJonathan Baets
Jonathan Baets
LALeonardo Almeida-Souza
Leonardo Almeida-Souza
EVEls De Vriendt
Els De Vriendt
JNJelena Nikodinovic
Jelena Nikodinovic
AJAlbena Jordanova
Albena Jordanova

27 November 2018 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
JPJovan Pesovic
Jovan Pesovic
SPStojan Perić
Stojan Perić
MBMiloš Brkušanin
Miloš Brkušanin
GBGoran Brajušković
Goran Brajušković
VRVidosava Rakočević-Stojanović
Vidosava Rakočević-Stojanović
DSDusanka Savic-Pavicevic
Dusanka Savic-Pavicevic
CTG expansions in DMPK gene, causing myotonic dystrophy type 1 (DM1), are characterized by pronounced somatic instability. A large proportion of variability of somatic instability is explained by expansion size and patient’s age at sampling, while individual-specific differences are attributed to additional factors. The age at onset is extremely variable in DM1, and inversely correlates with the expansion size and individual-specific differences in somatic instability. Three to five percent of DM1 patients carry repeat interruptions and some appear with later age at onset than expected for corresponding expansion size. Herein, we characterized somatic instability of interrupted DMPK expansions and the effect on age at onset in our previously described patients. Repeat-primed PCR showed stable structures of different types and patterns of repeat interruptions in blood cells over time and buccal cells. Single-molecule small-pool PCR quantification of somatic instability and mathematical modeling showed that interrupted expansions were characterized by lower level of somatic instability accompanied by slower progression over time. Mathematical modeling demonstrated that individual-specific differences in somatic instability had greater influence on age at onset in patients with interrupted expansions. Therefore, repeat interruptions have clinical importance for disease course in DM1 patients due to stabilizing effect on DMPK expansions in somatic cells.

1 December 2014 in Balkan Journal of Medical Genetics
Verified
Journal Article
Open access
MRMilic V. Rasic
Milic V. Rasic
DVD. Vojinovic
D. Vojinovic
JPJovan Pesovic
Jovan Pesovic
GMG. Mijalkovic
G. Mijalkovic
VLV. Lukic
V. Lukic
DSDusanka Savic-Pavicevic
Dusanka Savic-Pavicevic
Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy during childhood. Mutations in dystrophin (DMD) gene are also recognized as a cause of cognitive impairment. We aimed to determine the association between intelligence level and mutation location in DMD genes in Serbian patients with DMD. Forty-one male patients with DMD, aged 3 to 16 years, were recruited at the Clinic for Neurology and Psychiatry for Children and Youth in Belgrade, Serbia. All patients had defined DMD gene deletions or duplications [multiplex ligation- dependent probe amplification (MLPA), polymerase chain reaction (PCR)] and cognitive status assessment (Wechsler Intelligence Scale for Children, Brunet-Lezine scale, Vineland-Doll scale). In 37 patients with an estimated full scale intelligence quotient (FSIQ), six (16.22%) had borderline intelligence (70<FSIQ ≤85), while seven (18.92%) were intellectually impaired (FSIQ <70). The FSIQ was not associated with proximal and distal mutations when boundaries were set at exons 30 and 45. However, FSIQ was statistically significantly associated with mutation location when we assumed their functional consequence on dystrophin isoforms and when mutations in the 5’-untranslated region (5’UTR) of Dp140 (exons 45-50) were assigned to affect only Dp427 and Dp260. Mutations affecting Dp140 and Dp71/Dp40 have been associated with more frequent and more severe cognitive impairment. Finally, the same classification of mutations explained the greater proportion of FSIQ variability associated with cumulative loss of dystrophin isoforms. In conclusion, cumulative loss of dystrophin isoforms increases the risk of intellectual impairment in DMD and characterizing the genotype can define necessity of early cognitive interventions in DMD patients.

18 March 2013 in BioMed Research International
Verified
Journal Article
Open access
PDF file
DSDusanka Savic-Pavicevic
Dusanka Savic-Pavicevic
JMJelena Miladinović
Jelena Miladinović
MBMiloš Brkušanin
Miloš Brkušanin
SŠSaša Šviković
Saša Šviković
SDSvetlana Djurica
Svetlana Djurica
SRStanka Romac
Stanka Romac
Myotonic dystrophy type 1 (DM1) is the most common adult onset muscular dystrophy, presenting as a multisystemic disorder with extremely variable clinical manifestation, from asymptomatic adults to severely affected neonates. A striking anticipation and parental-gender effect upon transmission are distinguishing genetic features in DM1 pedigrees. It is an autosomal dominant hereditary disease associated with an unstable expansion of CTG repeats in the 3′-UTR of theDMPKgene, with the number of repeats ranging from 50 to several thousand. The number of CTG repeats broadly correlates with both the age-at-onset and overall severity of the disease. Expanded DM1 alleles are characterized by a remarkable expansion-biased and gender-specific germline instability, and tissue-specific, expansion-biased, age-dependent, and individual-specific somatic instability. Mutational dynamics in male and female germline account for observed anticipation and parental-gender effect in DM1 pedigrees, while mutational dynamics in somatic tissues contribute toward the tissue-specificity and progressive nature of the disease. Genetic test is routinely used in diagnostic procedure for DM1 for symptomatic, asymptomatic, and prenatal testing, accompanied with appropriate genetic counseling and, as recommended, without predictive information about the disease course. We review molecular genetics of DM1 with focus on those issues important for genetic testing and counseling.

13 January 2017 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
KLKatja Lohmann
Katja Lohmann
IMIkuo Masuho
Ikuo Masuho
DPDipak N. Patil
Dipak N. Patil
HBHauke Baumann
Hauke Baumann
EHEva Hebert
Eva Hebert
KMKirill A. Martemyanov
Kirill A. Martemyanov
Global developmental delay (GDD), often accompanied by intellectual disability, seizures and other features is a severe, clinically and genetically highly heterogeneous childhood-onset disorder. In cases where genetic causes have been identified, de novo mutations in neuronally expressed genes are a common scenario. These mutations can be best identified by exome sequencing of parent-offspring trios. De novo mutations in the guanine nucleotide-binding protein, beta 1 (GNB1) gene, encoding the Gβ1 subunit of heterotrimeric G proteins, have recently been identified as a novel genetic cause of GDD. Using exome sequencing, we identified 14 different novel variants (2 splice site, 2 frameshift and 10 missense changes) in GNB1 in 16 pediatric patients. One mutation (R96L) was recurrently found in three ethnically diverse families with an autosomal dominant mode of inheritance. Ten variants occurred de novo in the patients. Missense changes were functionally tested for their pathogenicity by assaying the impact on complex formation with Gγ and resultant mutant Gβγ with Gα. Signaling properties of G protein complexes carrying mutant Gβ1 subunits were further analyzed by their ability to couple to dopamine D1R receptors by real-time bioluminescence resonance energy transfer (BRET) assays. These studies revealed altered functionality of the missense mutations R52G, G64V, A92T, P94S, P96L, A106T and D118G but not for L30F, H91R and K337Q. In conclusion, we demonstrate a pathogenic role of de novo and autosomal dominant mutations in GNB1 as a cause of GDD and provide insights how perturbation in heterotrimeric G protein function contributes to the disease.

28 November 2016 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
SPStojan Peric
Stojan Peric
VRVidosava M. Rakocevic-Stojanovic
Vidosava M. Rakocevic-Stojanovic
GSGorana Mandic Stojmenovic
Gorana Mandic Stojmenovic
VIVera Ilic
Vera Ilic
MKMasa Kovacevic
Masa Kovacevic
GMGiovanni Meola
Giovanni Meola